FDA Generics Process Not Bound By 'Fairness,' DC Circ. Told
The U.S. Food and Drug Administration on Friday urged the D.C. Circuit to reverse a court order forcing it to approve a generic medication produced by Watson Laboratories Inc., saying the...To view the full article, register now.
Already a subscriber? Click here to view full article